These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29272251)

  • 1. Metformin-induced anticancer activities: recent insights.
    Safe S; Nair V; Karki K
    Biol Chem; 2018 Mar; 399(4):321-335. PubMed ID: 29272251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors.
    Nair V; Pathi S; Jutooru I; Sreevalsan S; Basha R; Abdelrahim M; Samudio I; Safe S
    Carcinogenesis; 2013 Dec; 34(12):2870-9. PubMed ID: 23803693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: role of specificity protein (Sp) transcription factors.
    Nair V; Sreevalsan S; Basha R; Abdelrahim M; Abudayyeh A; Rodrigues Hoffman A; Safe S
    J Biol Chem; 2014 Oct; 289(40):27692-701. PubMed ID: 25143389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC.
    Gandhy SU; Imanirad P; Jin UH; Nair V; Hedrick E; Cheng Y; Corton JC; Kim K; Safe S
    Oncotarget; 2015 Sep; 6(28):26359-72. PubMed ID: 26317792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzyl Isothiocyanate (BITC) Induces Reactive Oxygen Species-dependent Repression of STAT3 Protein by Down-regulation of Specificity Proteins in Pancreatic Cancer.
    Kasiappan R; Jutooru I; Karki K; Hedrick E; Safe S
    J Biol Chem; 2016 Dec; 291(53):27122-27133. PubMed ID: 27875298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.
    Jutooru I; Chadalapaka G; Lei P; Safe S
    J Biol Chem; 2010 Aug; 285(33):25332-44. PubMed ID: 20538607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.
    Hedrick E; Cheng Y; Jin UH; Kim K; Safe S
    Oncotarget; 2016 Apr; 7(16):22245-56. PubMed ID: 26967243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity Proteins (Sp) and Cancer.
    Safe S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity Protein Transcription Factors and Cancer: Opportunities for Drug Development.
    Safe S; Abbruzzese J; Abdelrahim M; Hedrick E
    Cancer Prev Res (Phila); 2018 Jul; 11(7):371-382. PubMed ID: 29545399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bortezomib Targets Sp Transcription Factors in Cancer Cells.
    Karki K; Harishchandra S; Safe S
    Mol Pharmacol; 2018 Oct; 94(4):1187-1196. PubMed ID: 30115673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways.
    Ikhlas S; Ahmad M
    Life Sci; 2017 Sep; 185():53-62. PubMed ID: 28755883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor Sp1, also known as specificity protein 1 as a therapeutic target.
    Safe S; Imanirad P; Sreevalsan S; Nair V; Jutooru I
    Expert Opin Ther Targets; 2014 Jul; 18(7):759-69. PubMed ID: 24793594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.
    Elmaci İ; Altinoz MA
    Biochem Genet; 2016 Oct; 54(5):573-618. PubMed ID: 27377891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin suppresses the invasive ability of pancreatic cancer cells by blocking autocrine TGF‑β1 signaling.
    Duan W; Qian W; Zhou C; Cao J; Qin T; Xiao Y; Cheng L; Li J; Chen K; Li X; Ma J; Ma Q
    Oncol Rep; 2018 Sep; 40(3):1495-1502. PubMed ID: 29956804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents.
    Jutooru I; Guthrie AS; Chadalapaka G; Pathi S; Kim K; Burghardt R; Jin UH; Safe S
    Mol Cell Biol; 2014 Jul; 34(13):2382-95. PubMed ID: 24732804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells.
    Abdelrahim M; Smith R; Burghardt R; Safe S
    Cancer Res; 2004 Sep; 64(18):6740-9. PubMed ID: 15374992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
    Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
    Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors.
    Li X; Pathi SS; Safe S
    BMC Cancer; 2015 Dec; 15():974. PubMed ID: 26673922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription Factors.
    Karki K; Hedrick E; Kasiappan R; Jin UH; Safe S
    Cancer Prev Res (Phila); 2017 Aug; 10(8):467-477. PubMed ID: 28673967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages.
    Incio J; Suboj P; Chin SM; Vardam-Kaur T; Liu H; Hato T; Babykutty S; Chen I; Deshpande V; Jain RK; Fukumura D
    PLoS One; 2015; 10(12):e0141392. PubMed ID: 26641266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.